Identification of a small-molecule Tim-3 inhibitor to potentiate T cell–mediated antitumor immunotherapy in preclinical mouse models
Shuaiya Ma,Ye Tian,Jiali Peng,Chaojia Chen,Xueqi Peng,Fabao Zhao,Zhenyu Li,Mengzhen Li,Fangcheng Zhao,Xue Sheng,Runzhe Zong,Yiquan Li,Jiwei Zhang,Mingyan Yu,Qingfen Zhu,Xiaoyu Tian,Yuyang Li,Markus R Neckenig,Huiqing Liu,Peng Zhan,Xuetian Yue,Zhuanchang Wu,Lifen Gao,Xiaohong Liang,Xinyong Liu,Chunyang Li,Chunhong Ma,Markus R. Neckenig
DOI: https://doi.org/10.1126/scitranslmed.adg6752
IF: 17.1
2023-11-16
Science Translational Medicine
Abstract:T cell immunoglobulin and mucin-containing molecule 3 (Tim-3), expressed in dysfunctional and exhausted T cells, has been widely acknowledged as a promising immune checkpoint target for tumor immunotherapy. Here, using a strategy combining virtual and functional screening, we identified a compound named ML-T7 that targets the FG-CC′ cleft of Tim-3, a highly conserved binding site of phosphatidylserine (PtdSer) and carcinoembryonic antigen–related cell adhesion molecule 1 (CEACAM1). ML-T7 enhanced the survival and antitumor activity of primary CD8 + cytotoxic T lymphocytes (CTLs) and human chimeric antigen receptor (CAR) T cells and reduced their exhaustion in vitro and in vivo. In addition, ML-T7 promoted NK cells' killing activity and DC antigen-presenting capacity, consistent with the reported activity of Tim-3. ML-T7 strengthened DCs' functions through both Tim-3 and Tim-4, which is consistent with the fact that Tim-4 contains a similar FG-CC′ loop. Intraperitoneal dosing of ML-T7 showed comparable tumor inhibitory effects to the Tim-3 blocking antibody. ML-T7 reduced syngeneic tumor progression in both wild-type and Tim-3 humanized mice and alleviated the immunosuppressive microenvironment. Furthermore, combined ML-T7 and anti–PD-1 therapy had greater therapeutic efficacy than monotherapy in mice, supporting further development of ML-T7 for tumor immunotherapy. Our study demonstrates a potential small molecule for selectively blocking Tim-3 and warrants further study.
cell biology,medicine, research & experimental